Intraindividual variability in bone markers in the urine

References

• Jensen J-E B, Sørensen H A, Kollerup G, Jensen L B, Sørensen O H. Biological variation of biochemical bone markers. Scand J Clin Invest 1994; 54: 36–39, (Suppl 219)
   Web of Science ®Google Scholar
• Seibel M J, Cosman F, Shen V, et al. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and oestrogen efficacy in postmenopausal osteoporosis. J Bone Miner Res 1993; 8: 881–89
   PubMed Web of Science ®Google Scholar
• Harris S T, Gertz B J, Genant H K, et al. The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodelling in early postmenopausal women. J Clin Endocrin Metab 1993; 76: 1399–1406
   PubMed Web of Science ®Google Scholar
• Adami S, Passeri M, Ortolani S, et al. Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis. Bone 1995; 17: 383–90
   PubMed Web of Science ®Google Scholar
• Christiansen C, Riis B J, Rødbro P. Prediction of rapid bone loss in postmenopausal women. Lancet 1987; i: 1105–07
   Google Scholar
• Hansen M A, Overgaard K, Riis B J, Christiansen C. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study. BMJ 1991; 303: 961–64
   PubMed Web of Science ®Google Scholar
• Falch J A, Sandvik L. Perimenopausal appendicular bone loss: A 10-year prospective study. Bone 1990; 11: 425–28
   PubMed Web of Science ®Google Scholar
• Nordin B EC, Cleghorn D B, Chatterton B E, Morrris H A, Need A G. A 5-year longitudinal study of forearm bone mass i 307 postmenopausal women. J Bone Miner Res 1993; 8: 1427–32
   PubMed Web of Science ®Google Scholar
• Schlemmer A, Hassager C, Jensen S B, Christiansen C. Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women. J Clin Endocrinol Metab 1992; 74: 476–80
   PubMed Web of Science ®Google Scholar
• Blumsohn R A, Hannon R A, Al-Dehaimi A W, Eastell R. Short-term intraindividual variability of markers of bone turnover in healthy adults. J Bone Miner Res 1994; 9: S153, (Suppl 1)
   PubMedGoogle Scholar
• Eastell R, Simmons P S, Colwell A, Assir A MA, Burritt M F, Russell G G, et al. Nyctohemeral changes in bone turnover assessed by serum bone Gla-protein concentration and urinary deoxypyridinoline excretion: effects of growth and ageing. Clinical Science 1992; 83: 375–382
   Web of Science ®Google Scholar
• Vanderschueren D, Gevers G, Raymaekers G, Devos P, Dequeker J. Sex- and age-related changes in bone and serum osteocalcin. Calcif Tissue Int 1990; 46: 179–182
   PubMed Web of Science ®Google Scholar
• Salamone L M, Glynn N, Black D, Epstein R S, Palermo L, Meilahn E, Kuller L H, Cauley J A. Body composition and bone mineral density in premenopausal and early perimenopausal women. J Bone Miner Res 1995; 10: 1762–68
   PubMedGoogle Scholar
• Black D M. Why elderly women should be screened and treated to prevent osteoporosis. Amer J Med 1995; 98: 67S–75S, (Suppl 2A)
   PubMed Web of Science ®Google Scholar
• Tremollieres F A, Pouilles J-M, Ribot C. Vertebral postmenopausal bone loss is reduced in overweight women: a longitudinal study in 155 early postmenopausal women. J Clin Endocrinol Metab 1993; 77: 683–6
   PubMed Web of Science ®Google Scholar
• Cummings S R, Nevitt M C, Browner W R, Stone K, Fox K M, Ensrud K E, Cauley J, Black D, Vogt T M. Risk factors for hip fracture in white women. N Engl J Med 1995; 332: 767–73
   PubMed Web of Science ®Google Scholar
• Forwood M R, Burr D B. Physical activity and bone mass: exercises in futility?. Bone & Min 1993; 21: 89–112
   PubMedGoogle Scholar
• Ohishi O, Kushida K, Takahashi M, Yagi K, Kawakami K, Horiuchi K, Inoue T. Urinary bone resorption markers in patients with metabolic bone disorders. Bone 1994; 15: 15–20
   PubMed Web of Science ®Google Scholar
• Fraser C G, Harris E K. Generation and application of data on biological variation in clinical chemistry. Critical Reviews in Clinical Laboratory Sciences 1989; 27: 409–37
   PubMed Web of Science ®Google Scholar
• Magid E, Petersen P H, Christen M. A note on the theory of reference changes. Scand J Clin Lab Invest 1992; 52: 95–101, (Suppl 208)
   PubMed Web of Science ®Google Scholar
• Harris E K. Effects of intra- and interindividual variation on the appropriate use of normal ranges. Clin Chem 1974; 20: 1535–42
   PubMed Web of Science ®Google Scholar
• Kollerup G, Thamsborg G, Bhatia H, Sørensen O H. Quantitation of urinary hydroxypyridinium cross-links from collagen by high-performance liquid chromatography. Scand J Clin Lab Invest 1992; 52: 657–662
   PubMed Web of Science ®Google Scholar
• Kivirikko K I, Laitinen O, Prockop D J. Modification of a specific assay for hydroxyproline in urine. Analyt Biochem 1967; 19: 249–55
   PubMed Web of Science ®Google Scholar
• Vasikaran S D, McCloskey E V, Kahn S, Kanis J A. Intra-individual variation in fasting urinary calcium- and hydroxyproline-creatinine ratios measured in metabolic bone clinic patients as both outpatients and inpatients. Ann Clin Biochem 1994; 31: 272–76
   PubMedGoogle Scholar
• Calabresi E, Lasagni L, Franceschelli F, Bartolini L, Serio M, Brandi M L. Use of an internal standard to measure pyridinoline and deoxypyridinoline in the urine. Clin Chem 1994; 40: 336–37
   PubMedGoogle Scholar
• Robins S P, Duncan A, Wilson N, Evans B J. Standardization of pyridinium crosslinks, pyridinoline and deoxypyridinoline, for use as biochemical markers of collagen degradation. Clin Chem 1996; 42: 1621–26
   PubMed Web of Science ®Google Scholar
• Reeve J, Pearson J, Mitchell A, et al. Evolution of spinal bone loss and biochemical markers of bone remodeling after menopause in normal women. Calcif Tissue Int. 1995; 57: 105–110
   PubMedGoogle Scholar
• Keen R W, Hall G M, Nandra D, et al. Early postmenopausal bone loss and biochemical markers. Bone 1995; 16: 108S, (Suppl 1)
   Google Scholar